| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
|
JAMA
|
2003
|
7.42
|
|
2
|
Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
|
J Clin Hypertens (Greenwich)
|
2002
|
6.03
|
|
3
|
Sodium intake and mortality in the NHANES II follow-up study.
|
Am J Med
|
2006
|
3.24
|
|
4
|
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
|
Am J Cardiol
|
2007
|
3.10
|
|
5
|
The impact of serum uric acid on cardiovascular outcomes in the LIFE study.
|
Kidney Int
|
2004
|
2.96
|
|
6
|
ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.
|
Arch Intern Med
|
2009
|
2.02
|
|
7
|
Sodium intake and mortality follow-up in the Third National Health and Nutrition Examination Survey (NHANES III).
|
J Gen Intern Med
|
2008
|
1.79
|
|
8
|
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
|
Hypertension
|
2006
|
1.73
|
|
9
|
A call for higher standards of evidence for dietary guidelines.
|
Am J Prev Med
|
2008
|
1.69
|
|
10
|
Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty.
|
J Am Coll Cardiol
|
2009
|
1.67
|
|
11
|
Acute myocardial infarction hospitalization in the United States, 1979 to 2005.
|
Am J Med
|
2010
|
1.63
|
|
12
|
Renin-angiotensin system blockers may create more risk than reward for sodium-depleted cardiovascular patients with high plasma renin levels.
|
Am J Hypertens
|
2013
|
1.57
|
|
13
|
Hypertension control at physicians' offices in the United States.
|
Am J Hypertens
|
2008
|
1.56
|
|
14
|
Renal dysfunction and ischemic heart disease mortality in a hypertensive population.
|
J Hypertens
|
2005
|
1.55
|
|
15
|
Is high pulse pressure a marker of preclinical cardiovascular disease?
|
Hypertension
|
2005
|
1.53
|
|
16
|
Enduring direct association of baseline plasma renin activity with all-cause and cardiovascular mortality in hypertensive patients.
|
Am J Hypertens
|
2011
|
1.27
|
|
17
|
Blood-pressure-related disease is a global health priority.
|
Lancet
|
2008
|
1.22
|
|
18
|
Characteristics of children with primary hypertension seen at a referral center.
|
Pediatr Nephrol
|
2005
|
1.15
|
|
19
|
The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease.
|
Vasc Med
|
2012
|
1.13
|
|
20
|
Exercise, body mass index, caloric intake, and cardiovascular mortality.
|
Am J Prev Med
|
2003
|
1.10
|
|
21
|
Variations in hip fracture hospitalization rates among different race/ethnicity groups in New York City.
|
Ethn Dis
|
2004
|
1.08
|
|
22
|
Differential use of coronary revascularization and hospital mortality following acute myocardial infarction.
|
Arch Intern Med
|
2003
|
1.05
|
|
23
|
Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
|
J Clin Hypertens (Greenwich)
|
2011
|
1.04
|
|
24
|
Impact of the increasing burden of diabetes on acute myocardial infarction in New York City: 1990-2000.
|
Diabetes
|
2006
|
1.02
|
|
25
|
Declining US stroke hospitalization since 1997: National Hospital Discharge Survey, 1988-2004.
|
Neuroepidemiology
|
2008
|
1.01
|
|
26
|
Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States.
|
Am Heart J
|
2006
|
1.00
|
|
27
|
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study.
|
J Am Coll Cardiol
|
2004
|
0.99
|
|
28
|
Clinical characteristics of stroke among Chinese in New York City.
|
Ethn Dis
|
2004
|
0.99
|
|
29
|
Dissociation of hospitalization and mortality trends for myocardial infarction in the United States from 1988 to 1997.
|
Am J Med
|
2002
|
0.98
|
|
30
|
Sodium and cardiovascular disease.
|
N Engl J Med
|
2014
|
0.95
|
|
31
|
Is geography destiny for patients in New York with myocardial infarction?
|
Am J Med
|
2003
|
0.95
|
|
32
|
Sodium, blood pressure, and cardiovascular disease.
|
Curr Opin Cardiol
|
2007
|
0.94
|
|
33
|
Vascular disease among hospitalized multiple sclerosis patients.
|
Neuroepidemiology
|
2008
|
0.93
|
|
34
|
Beyond hypertension toward guidelines for cardiovascular risk reduction.
|
Am J Hypertens
|
2004
|
0.92
|
|
35
|
The Cochrane review of sodium and health.
|
Am J Hypertens
|
2011
|
0.83
|
|
36
|
Gender differences of revascularization in patients with acute myocardial infarction.
|
Am J Cardiol
|
2006
|
0.82
|
|
37
|
Exercise and cardiovascular outcomes by hypertensive status: NHANES I epidemiological follow-up study, 1971-1992.
|
Am J Hypertens
|
2005
|
0.82
|
|
38
|
Quality of life in hypertensive patients: does it matter and should we measure it?
|
J Hypertens
|
2005
|
0.82
|
|
39
|
Stroke risk among Chinese immigrants in New York City.
|
J Immigr Minor Health
|
2006
|
0.81
|
|
40
|
Dietary Sodium and Cardiovascular Disease Risk.
|
N Engl J Med
|
2016
|
0.81
|
|
41
|
Blood-pressure-related disease is a global health priority.
|
Am J Hypertens
|
2008
|
0.80
|
|
42
|
Access to revascularization among patients with acute myocardial infarction in New York City--impact of hospital resources.
|
J Urban Health
|
2006
|
0.80
|
|
43
|
Blood-pressure-related disease is a global health priority.
|
J Hypertens
|
2008
|
0.79
|
|
44
|
Podagra, uric acid, and cardiovascular disease.
|
Circulation
|
2007
|
0.79
|
|
45
|
Does blood pressure control require a Cuban-style revolution?
|
J Hypertens
|
2006
|
0.78
|
|
46
|
Resistant hypertension: a clinical syndrome in search of a definition.
|
Am J Hypertens
|
2008
|
0.78
|
|
47
|
Hypertension control: improved, but not enough!
|
Am J Hypertens
|
2007
|
0.77
|
|
48
|
The return on INVEST.
|
JAMA
|
2003
|
0.76
|
|
49
|
ALLHAT and beyond.
|
Am J Hypertens
|
2003
|
0.75
|
|
50
|
Salt: data and speculation.
|
Clin Auton Res
|
2002
|
0.75
|
|
51
|
Estimation of death rates from pandemic influenza.
|
Lancet
|
2007
|
0.75
|
|
52
|
Does supplemental private insurance affect care of Medicare recipients hospitalized for myocardial infarction?
|
Am J Public Health
|
2004
|
0.75
|
|
53
|
Hypertension in sub-Saharan Africa: what physicians can do!
|
Am J Hypertens
|
2009
|
0.75
|
|
54
|
Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT.
|
J Clin Hypertens (Greenwich)
|
2013
|
0.75
|
|
55
|
Blood pressure measures, relative and absolute risk, and international differences.
|
J Hypertens
|
2002
|
0.75
|
|
56
|
More about plasma renin and cardiovascular mortality.
|
Eur Heart J
|
2011
|
0.75
|
|
57
|
Hypertension, silver bullets and faded dreams.
|
J Hypertens
|
2004
|
0.75
|
|
58
|
Dietary salt and cardiovascular disease.
|
Lancet
|
2011
|
0.75
|
|
59
|
Hypertension control and kidney disease: some questions answered, many remain.
|
JAMA
|
2002
|
0.75
|
|
60
|
AJH Peer Review 2014.
|
Am J Hypertens
|
2015
|
0.75
|
|
61
|
Clinical problems in the management of hypertension 1) Prehypertension: should we treat? 2)The very elderly: how should we treat.
|
J Clin Hypertens (Greenwich)
|
2004
|
0.75
|
|
62
|
Low sodium diet after DASH: has the situation changed? Dietary Approaches to Stop Hypertension.
|
Curr Hypertens Rep
|
2002
|
0.75
|
|
63
|
Randomized clinical trials: prescriptions to be applied with caution!
|
Am J Hypertens
|
2008
|
0.75
|
|
64
|
Editor's Note. The Renin-Angiotensin System: Today and Tomorrow in Research and Clinical Practice.
|
Am J Hypertens
|
2011
|
0.75
|
|
65
|
Revascularization among patients with acute myocardial infarction complicated by cardiogenic shock and impact of American College of Cardiology/American Heart Association guidelines.
|
Am J Cardiol
|
2004
|
0.75
|
|
66
|
AJH goes to China.
|
Am J Hypertens
|
2008
|
0.75
|
|
67
|
AJH, globalization, and the Chinese Journal of Hypertension.
|
Am J Hypertens
|
2009
|
0.75
|
|
68
|
Glucose-cholesterol interaction magnifies coronary heart disease risk for hypertensive patients.
|
Hypertension
|
2004
|
0.75
|
|
69
|
The state of the journal: a report to AJH readers, reviewers, and authors.
|
Am J Hypertens
|
2011
|
0.75
|
|
70
|
Renal dysfunction predicts attenuation of ischemic heart disease mortality risk from elevated glucose among treated hypertensive patients.
|
Am J Hypertens
|
2006
|
0.75
|
|
71
|
How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?
|
Stat Med
|
2012
|
0.75
|